Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery

被引:151
作者
Gonzalez-Mira, E. [1 ]
Egea, M. A. [1 ]
Souto, E. B. [2 ,3 ]
Calpena, A. C. [4 ]
Garcia, M. L. [1 ]
机构
[1] Univ Barcelona, Dept Phys Chem, Fac Pharm, Inst Nanosci & Nanotechnol, E-08028 Barcelona, Spain
[2] Fernando Pessoa Univ, Fac Hlth Sci, P-4200150 Oporto, Portugal
[3] Univ Tras Os Montes & Alto Douro IBB CGB UTAD, Inst Biotechnol & Bioengn, Ctr Genet & Biotechnol, P-5000801 Vila Real, Portugal
[4] Univ Barcelona, Dept Biopharm & Pharmaceut Technol, Fac Pharm, E-08028 Barcelona, Spain
关键词
SOLID LIPID NANOPARTICLES; HIGH-PRESSURE HOMOGENIZATION; PHYSICOCHEMICAL PROPERTIES; CARRIERS NLC; DRUG-RELEASE; IN-VITRO; STABILITY; SYSTEM; SKIN; SURFACTANTS;
D O I
10.1088/0957-4484/22/4/045101
中图分类号
TB3 [工程材料学];
学科分类号
082905 [生物质能源与材料];
摘要
The purpose of this study was to design and optimize a new topical delivery system for ocular administration of flurbiprofen (FB), based on lipid nanoparticles. These particles, called nanostructured lipid carriers (NLC), were composed of a fatty acid (stearic acid (SA)) as the solid lipid and a mixture of Miglyol (R) 812 and castor oil (CO) as the liquid lipids, prepared by the hot high pressure homogenization method. After selecting the critical variables influencing the physicochemical characteristics of the NLC (the liquid lipid (i.e. oil) concentration with respect to the total lipid (cOil/L (wt%)), the surfactant and the flurbiprofen concentration, on particle size, polydispersity index and encapsulation efficiency), a three-factor five-level central rotatable composite design was employed to plan and perform the experiments. Morphological examination, crystallinity and stability studies were also performed to accomplish the optimization study. The results showed that increasing cOil/L (wt%) was followed by an enhanced tendency to produce smaller particles, but the liquid to solid lipid proportion should not exceed 30 wt% due to destabilization problems. Therefore, a 70: 30 ratio of SA to oil (miglyol + CO) was selected to develop an optimal NLC formulation. The smaller particles obtained when increasing surfactant concentration led to the selection of 3.2 wt% of Tween (R) 80 (non-ionic surfactant). The positive effect of the increase in FB concentration on the encapsulation efficiency (EE) and its total solubilization in the lipid matrix led to the selection of 0.25 wt% of FB in the formulation. The optimal NLC showed an appropriate average size for ophthalmic administration (228.3 nm) with a narrow size distribution (0.156), negatively charged surface (-33.3 mV) and high EE (similar to 90%). The in vitro experiments proved that sustained release FB was achieved using NLC as drug carriers. Optimal NLC formulation did not show toxicity on ocular tissues.
引用
收藏
页数:15
相关论文
共 59 条
[1]
Development, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis [J].
Agrawal, Yogeeta ;
Petkar, Kailash C. ;
Sawant, Krutika K. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2010, 401 (1-2) :93-102
[2]
*APV HOM GROUP, 1996, HDB APV HOM GROUP, P3850
[3]
Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications [J].
Araujo, J. ;
Gonzalez-Mira, E. ;
Egea, M. A. ;
Garcia, M. L. ;
Souto, E. B. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2010, 393 (1-2) :167-175
[4]
Effect of polymer viscosity on physicochemical properties and ocular tolerance of FB-loaded PLGA nanospheres [J].
Araujo, J. ;
Vega, E. ;
Lopes, C. ;
Egea, M. A. ;
Garcia, M. L. ;
Souto, E. B. .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2009, 72 (01) :48-56
[5]
Nanomedicines for ocular NSAIDs: safety on drug delivery [J].
Araujo, Joana ;
Gonzalez, Elisabet ;
Egea, Maria Antonia ;
Garcia, Marisa Luisa ;
Souto, Eliana B. .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2009, 5 (04) :394-401
[6]
Lipid nanoparticles for transdermal delivery of flurbiprofen: formulation, in vitro, ex vivo and in vivo studies [J].
Bhaskar, Kesavan ;
Anbu, Jayaraman ;
Ravichandiran, Velayutham ;
Venkateswarlu, Vobalaboina ;
Rao, Yamsani Madhusudan .
LIPIDS IN HEALTH AND DISEASE, 2009, 8
[7]
Turbiscan Lab® Expert analysis of the stability of ethosomes® and ultradeformable liposomes containing a bilayer fluidizing agent [J].
Celia, Christian ;
Trapasso, Elena ;
Cosco, Donato ;
Paolino, Donatella ;
Fresta, Massimo .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2009, 72 (01) :155-160
[8]
Modified Booth equation for the calculation of zeta potential [J].
Deshiikan, SR ;
Papadopoulos, KD .
COLLOID AND POLYMER SCIENCE, 1998, 276 (02) :117-124
[9]
DUPRAT P, 1976, EUR J TOXICOL ENV HY, V9, P171
[10]
Correlation between long-term stability of solid lipid nanoparticles (SLN™) and crystallinity of the lipid phase [J].
Freitas, C ;
Müller, RH .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1999, 47 (02) :125-132